🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Uttara Saran

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-3705-5123

Biochemistry, Genetics and Molecular BiologyEnvironmental ScienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Urolithin A analog inhibits castration-resistant prostate cancer by targeting the androgen receptor and its variant, androgen receptor-variant 7”.

Urolithin A analog inhibits castration-resistant prostate cancer by targeting the androgen receptor and its variant, androgen receptor-variant 7

Frontiers in Pharmacology(2023)10.3389/fphar.2023.1137783

N/A

0.360DataRank · unranked

10 citations

Ashish Tyagi, Uttara Saran, Venkatesh Kolluru, Becca V. Baby, Venkat R. Chirasani +7 more

A Comprehensive Transcriptomic Analysis of Arsenic-Induced Bladder Carcinogenesis

Cells(2022)10.3390/cells11152435

N/A

0DataRank · unranked

17 citations

Balaji Chandrasekaran, Ashish Tyagi, Ajit Kumar Navin, Uttara Saran, Rosalyn M. Adam +2 more

Antiandrogen-Equipped Histone Deacetylase Inhibitors Selectively Inhibit Androgen Receptor (AR) and AR-Splice Variant (AR-SV) in Castration-Resistant Prostate Cancer (CRPC)

Cancers(2023)10.3390/cancers15061769

N/A

0DataRank · unranked

10 citations

Subhasish Tapadar, Bocheng Wu, Uttara Saran, Ashish Tyagi, Alexis Johnston +4 more